Loading clinical trials...
Loading clinical trials...
Study Evaluating Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients
Conditions
Interventions
Genuair®
Breezhaler®
Locations
6
Germany
Almirall investigative site 2
Berlin, Germany
Almirall investigative site 1
Munich, Germany
Almirall investigative site 3
Barcelona, Spain
Almirall investigative site 4
Palma de Mallorca, Spain
Almirall investigative site 5
Glasgow, United Kingdom
Almirall investigative site 6
Newcastle upon Tyne, United Kingdom
Start Date
July 1, 2013
Primary Completion Date
October 1, 2013
Completion Date
October 1, 2013
Last Updated
May 29, 2015
NCT07477600
NCT07382258
NCT07195838
NCT06595784
NCT06714721
NCT06172712
Lead Sponsor
Almirall, S.A.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions